Chemoinformaics analysis of 4-Hydroxy-5-methylfuran-3-carboxylic acid
| Molecular Weight | 142.11 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 21 |
| Exact Molecular Weight | 142.027 | nRing | 1 |
| Solubility: LogS | -2.323 | nHRing | 1 |
| Solubility: LogP | 1.375 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 17.2288 |
| nHD | 2 | BPOL | 8.62324 |
| QED | 0.87 |
| Synth | 4.238 |
| Natural Product Likeliness | 2.339 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.164 |
| HIA | 0.008 |
| CACO-2 | -4.802 |
| MDCK | 0.000018 |
| BBB | 0.975 |
| PPB | 0.536929 |
| VDSS | 1.874 |
| FU | 0.369846 |
| CYP1A2-inh | 0.126 |
| CYP1A2-sub | 0.947 |
| CYP2c19-inh | 0.217 |
| CYP2c19-sub | 0.9 |
| CYP2c9-inh | 0.071 |
| CYP2c9-sub | 0.543 |
| CYP2d6-inh | 0.336 |
| CYP2d6-sub | 0.811 |
| CYP3a4-inh | 0.471 |
| CYP3a4-sub | 0.928 |
| CL | 6.091 |
| T12 | 0.587 |
| hERG | 0.052 |
| Ames | 0.052 |
| ROA | 0.561 |
| SkinSen | 0.091 |
| Carcinogencity | 0.279 |
| EI | 0.012 |
| Respiratory | 0.905 |
| NR-Aromatase | 0.737 |
| Antiviral | No |
| Prediction | 0.931808 |